Accolade Past Performance
Past criteria checks 0/6
Accolade's earnings have been declining at an average annual rate of -54.8%, while the Healthcare industry saw earnings growing at 11.9% annually. Revenues have been growing at an average rate of 31.7% per year.
Earnings growth rate
EPS growth rate
|Healthcare Industry Growth||11.9%|
|Revenue growth rate||31.7%|
|Return on equity||-97.0%|
|Last Earnings Update||28 Feb 2023|
Recent past performance updates
Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?May 02
An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% UndervaluedFeb 05
Accolade: Inching Closer To ProfitabilityOct 17
Accolade Q2 2023 Earnings PreviewOct 05
Accolade: Fair And Reasonably Priced, But Needs More TimeAug 09
Accolade Q1 2023 Earnings PreviewJun 29
Accolade: Little Recent ApplauseMar 28
Accolade Impresses With Revenue Growth But Faces Operating LossesDec 16
Accolade: I May Add To My PositionOct 18
Accolade, Inc. (NASDAQ:ACCD) Just Reported And Analysts Have Been Lifting Their Price TargetsJul 11
Accolade, Inc. 2021 Q4 - Results - Earnings Call PresentationMay 06
Here's Why We're Not Too Worried About Accolade's (NASDAQ:ACCD) Cash Burn SituationMar 19
Is Accolade, Inc. (NASDAQ:ACCD) Popular Amongst Institutions?Jan 15
Accolade is up 7% on acquisition of 2nd.MDJan 14
Accolade Inc.: Bullish Outlook As Its HealthTech Platform Helps Companies SaveJan 12
Accolade, Inc. 2021 Q3 - Results - Earnings Call PresentationJan 11
Accolade Q3 2021 Earnings PreviewJan 06
Earnings and Revenue History
Quality Earnings: ACCD is currently unprofitable.
Growing Profit Margin: ACCD is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ACCD is unprofitable, and losses have increased over the past 5 years at a rate of 54.8% per year.
Accelerating Growth: Unable to compare ACCD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ACCD is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-9.8%).
Return on Equity
High ROE: ACCD has a negative Return on Equity (-97.02%), as it is currently unprofitable.